Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic In Vitro Diagnostics Deals: Therapeutic Area Trends Decision Resources, Inc., Dec 2006, Pages: 27   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   IVD (in vitro diagnostics) tests are essential to the practice of health care worldwide: an estimated 60-70% of medical decisions involve a diagnostic test. This report focuses on IVD industry deals of the last few years and what they reveal about the current strategies of some of the industry’s larger and smaller companies. Get the Answers You Need to Shape Your Strategy Currently, IVD company revenues pale in comparison to those of the larger biopharmaceutical companies, but there are signs of steady growth in this highly segmented market. What is the value of today’s global IVD market? How fast is it growing? Which segments are currently most profitable? Which are showing strong growth? Which IVD suppliers accounted for nearly 80% of worldwide sales in 2005? Several large IVD M&As have occurred in recent years, but licensing deals have been the most common type. How do licensing deals benefit IVD suppliers? What do big pharmaceutical and diagnostics companies gain? Which companies have been most active in M&A and licensing deals? What does this activity indicate about the future of the IVD industry? The overall oncology therapeutic area has accounted for the majority of IVD deals to date. Which oncology segments are most active? What other therapeutic areas are generating notable deals? What types of diagnostic assays and tests are most in demand? Which are being offered as “companion diagnostics” to therapeutic agents? What new, DNA-based tests are in development? Scope The IVD marketplace: Current size, growth, segmentation, disease areas, major and smaller IVD suppliers, 2005 sales. IVD mergers and acquisitions: 2005-2006, companies, segments, values, significance. IVD deals by disease areas: Oncology, cardiovascular, infectious diseases, other therapeutic areas. IVD deal strategies: Different strategies drive deals in different tiers of the IVD industry. Future IVD deals: Potential mergers and acquisitions as diagnostics change and the IVD market continues to grow. Customers who bought this item also bought PartneringReview 2006: BioPharma Deal Making Volume 2 - Deals and Alliances By Therapy Area U.S. Therapeutic Monoclonal Antibodies Markets PartneringReview 2006: BioPharma Deal Making Volume 5 - Deals and Alliances By Deal Type Partneringreview 2006: Biopharma Deal Making Volume 6 - Deals and Alliances By Industry Sector Strategic Analysis of the Therapeutic Peptide Market in Europe High Growth Diagnostics: Technology and Market Analyses Molecular Diagnostics Markets Diagnostics Dealmaking Activity - First Quarter 2004 to Third Quarter 2005

		Top of page

All rights reserved. Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster